FDA approves weight-loss drug Wegovy to reduce heart-disease risks
Washington Post
The U.S. Food and Drug administration approved the weight-loss drug Wegovy as a treatment to reduce cardiovascular risk in adults who are overweight, the first approval of its kind.
https://www.washingtonpost.com/business/2024/03/08/wegovy-heart-disease-fda/